Cellular phenotype and extracellular vesicles: Basic and clinical considerations

Stem Cells and Development

Volumn 23, Issue 13, 2014, Pages 1429-1436

  Quesenberry, Peter J ^a   Goldberg, Laura R ^a   Aliotta, Jason M ^a   Dooner, Mark S ^a   Pereira, Mandy G ^a   Wen, Sicheng ^a   Camussi, Giovanni ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AQUAPORIN 5; BIRC8 PROTEIN; CLARA CELL PROTEIN; DNA; MESSENGER RNA; MICRORNA; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ANCHORAGE INDEPENDENT GROWTH; BONE MARROW CELL; BONE MARROW TOXICITY; CANCER CELL; CANCER INHIBITION; CELL EXPANSION; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFER; CELL VACUOLE; EPIGENETICS; EXOSOME; EXTRACELLULAR VESICLE; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; KIDNEY INJURY; LIVER INJURY; LIVER PARENCHYMA; LUNG PARENCHYMA; LUNG VESICLE; MESENCHYMAL STEM CELL; MULTIVESICULAR BODY; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INJURY; REVIEW; TISSUE REPAIR; TOXICITY; UPREGULATION; ANIMAL; CELL CULTURE; COCULTURE; MESENCHYMAL STROMA CELL; METABOLISM; PARACRINE SIGNALING; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; COCULTURE TECHNIQUES; EXOSOMES; HUMANS; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; PHENOTYPE; RNA, MESSENGER;

EID: 84901399458     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0594     Document Type: Review

References (53)

1. Heijnen HF, AE Schiel, R Fijnheer, HJ Geuze and JJ Sixma. (1999). Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alphagranules. Blood 94:3791-3799.
2. Johnstone RM, M Adam, JR Hammond, L Orr and C Turbide. (1987). Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262: 9412-9420.
3. Zitvogel L, A Regnault, A Lozier, J Wolfers, C Flament, D Tenza, P Ricciardi-Castagnoli, G Raposo and S Amigorena. (1998). Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat Med 4:594-600. (Pubitemid 28237359)
4. Denzer K, MJ Kleijmeer, HF Heijnen, W Stoorvogel and HJ Geuze. (2000). Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 19:3365-3374.
5. The'ry C, L Zitvogel and S Amigorena. (2002). Exosomes: Composition, biogenesis and function. Nat Rev Immunol 8:569-579. (Pubitemid 37328732)
6. Aharon A and B Brenner. (2011). Microparticles and pregnancy complications. Hromb Res; 127(Suppl 3):S67-S71.
7. Witer KW, SL Sarbanes, J Liu and JE Clemens. (2011). A Plasma microRNA signature of acute leniviral infection: Biomarkers of CAN disease. AIDS 204:1104-1114.
8. Mobius-Winkler S, T Hilberg, K Menzel, E Golla, A Burman, G Schuler, et al. (2009). Time dependent mobilization of circulating progenitor cells during strenuous exercise in healthy individuals. J Appl Physiol 107:1943-1950.
9. Sossdorf M, GP Otto, RA Claus, HH Gabriel and W Loesche. (2011). Cell-derived microparticles promote coagulation after moderate exercise. Med Sci Sports Exerc 43:1169-1176.
10. Chaar V, M Romana, J Tripette, C Broquere, MG Huisse, O Hue, et al. (2011). Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc 47:15-25.
11. Strohacker K, WL Breslin, KC Carpenter, TR Davidson, NH Agha and BK McFarlin. (2012). Moderate-intensity, premeal cycling blunts postprandial increases in monocyte cell surface CD18 and CD11a and endothelial microparticles following a high-fat meal in young adults. Appl Physiol Nutr Metab 37:530-539.
12. George JN, LL Thoi, LM McManus and TA Reimann. (1982). Isolation of human platelet membrane microparticles from plasma and serum. Blood 60:834-840. (Pubitemid 12001441)
13. Bard MP, JP Hegmans, A Hemmes, TM Luider, R Willemsen, LA Severijnen, et al. (2004). Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Repair Cell Mol Biol 31:114-121. (Pubitemid 38888047)
14. Perkumas KM, EA Hoffman, BS McKay, RR allingham and WD Stamer. (2007). Myocilin-Associated exosomes in human ocular samples. Exp eye Res 84:209-212.
15. Admyre C, SM Johansson, KR Qazi, JJ Filen, R lahesmaa, M Norman, et al. (2007). Exosomes with immune modulatory features are present in human breast milk. J Immunol 179:1969-1978.
16. Dai S, D Wei, Z Wu, X Zhou, X Wei, H Huang, et al. (2008). Phase 1 clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16:782-790. (Pubitemid 351426181)
17. Asea A, C Jean-Pierre, P Kaur, P Rao, IM Linhares, D Skupski, et al. (2008). Heat shock protein-containing exosomes in mid-Trimester amniotic fluids. J Reprod Immunol 79:12-17.
18. Poliakov A, M Spilman, T Dokland, CL Amling and JA Mobley. (2009). Structural heterogeneity and protein composition of exosome-like vesicles (prostaomes) in human semen. Prostate 69:159-167.
19. Keller S, J Ridinger, AK Rupp, JW Janssen and P Altevogt. (2011). Body fluid derived vesicles as a novel template for clinical diagnostics. J Transl Med 9:86.
20. Street JM, PE Barran, CL Mackay, S Weidt, C Balmforth, TS Walsh, et al. (2012). Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 10:5.
21. Raj DA, I Fiume, G Capasso and G Pocsfalvi. (2012). A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int 81:1263-1272.
22. Thery C, S amigorena, G Raposo and A Clayton. (2006). Isolation and characterization of exosomes from cell culture supernatants and biologic fluids. Curr Protoc Cell Biol DOI: 10.1002/0471143030.cb0322s30.
23. Lamparski HG, A Metha-Damani, JY Yao, S Patel, DH Hsu, C Ruegg, et al. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270:211-226.
24. Kadio I, P Narayanasamy, PK Dash, W Zhang and HE Gendelman. (2012). Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J Immunol 189:744-754.
25. Ismail N, Y Wang, D Dakhlallah, L Moldovan, K Agarwal, K Batte, et al. (2012). Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 6:984-995.
26. Ratajczak J, K Miekus, M Kucia, J Zhang, R Reca, P Dvorak, MZ Ratajczak. (2006). Embryonic stem cellderived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 5:847-856.
27. Ratajczak J, M Wysoczynski, F Hayek, A Janowska-Wieczorek, MZ Ratajczak. (2006). Membrane-derived microvesicles: Important and underappreciated mediators of cell-To-cell communication. Leukemia 9:1487-1495. (Pubitemid 44264090)
28. Aliotta JM, P Keaney, M Passero, MS Dooner, J Pimentel, D Greer, D Demers, B Foster, A Peterson, et al. (2006). Bone marrow production of lung cells: The impact of GCSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol 34:230-241. (Pubitemid 43184328)
29. Aliotta JM, FM Sanchez-Guijo, GJ Dooner, KW Johnson, MS Dooner, KA Greer, D Greer, J Pimentel, LM Kolankiewicz, et al. (2007). Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: A novel mechanism for phenotype modulation. Stem Cells 25:2245-2256. (Pubitemid 47480483)
30. Aliotta JM, M Pereira, KW Johnson, N de Paz, MS Dooner, N Puente, C Ayala, K Brilliant, D Berz, et al. (2010). Microvesicle entry into marrow cells mediates tissuespecific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 38:233-245.
31. Valadi H, K Ekström, A Bossios, M Sjöstrand, JJ Lee and JO Lötvall. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659. (Pubitemid 47214727)
32. Deregibus MC, V Cantaluppi, R Calogero, M Lo Iacono, C Tetta, L Biancone, S Bruno, B Bussolati and G Camussi. (2007). Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448. (Pubitemid 47523165)
33. Abedi M, DA Greer, GA Colvin, DA Demers, MS Dooner, JA Harpel, HU Weier, JF Lambert and PJ Quesenberry. (2004). Robust conversion of marrow cells to skeletal muscle with formation of marrow-derived muscle cell colonies: A multifactorial process. Exp Hematol 32:426-434. (Pubitemid 38624326)
34. Dooner M, J Cerny, G Colvin, D Demers, J Pimentel, D Greer, M Abedi, C McAuliffe and P Quesenberry. (2004). Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis 32:47-51. (Pubitemid 38147695)
35. Badiavas EV, M Abedi, J Butmarc, V Falanga and P Quesenberry. (2003). Participation of bonemarrow derived cells in cutaneous wound healing. J Cell Physiol 196:245-250. (Pubitemid 36775870)
36. Quesenberry PJ, G Dooner, M Dooner, M Abedi. (2005). Developmental biology: Ignoratio elenchi: Red herrings in stem cell research. Science 308:1121-1122. (Pubitemid 40696420)
37. Anderson DJ, FH Gage and IL Weissman. (2001). Can stem cells cross lineage boundaries? Nat Med 7:393-395. (Pubitemid 32298529)
38. Aliotta JM, D Lee, N Puente, S Faradyan, EH Sears, A Amaral, L Goldberg, MS Dooner, M Pereira and PJ Quesenberry. (2012). Progenitor/stem cell fate determination: Interactive dynamics of cell cycle and microvesicles. Stem Cells Dev 2:1627-1638.
39. Aliotta JM, M Pereira, M Li, A Amaral, A Sorokina, MS Dooner, EH Sears, K Brilliant, B Ramratnam, DC Hixson and PJ Quesenberry. (2012). Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J Extracell Vesicles 1.
40. Gatti S, S Bruno, MC Deregibus, A Sordi, V Cantaluppi, C Tetta and G Camussi. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 5:1474-1483.
41. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 5: 1053-1067.
42. Bruno S, C Grange, F Collino, MC Deregibus, V Cantaluppi, L Biancone, C Tetta and G Camussi. (2012). Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7:e33115.
43. Tetta C, AL Consiglio, S Bruno, E Tetta, E Gatti, M Dobreva, F Cremonesi and G Camussi. (2012). The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J 16:212-221.
44. Ranghino A, V Cantaluppi, C Grange, L Vitillo, F Fop, L Biancone, MC Deregibus, C Tetta, GP Segoloni and G Camussi. (2012). Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol 1:75-85.
45. Herrera MB, V Fonsato, S Gatti, MC Deregibus, A Sordi, D Cantarella, R Calogero, B Bussolati, C Tetta and G Camussi. (2009). Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 6B:1605-1618.
46. Aliotta JM, PJ Keaney, RR Warburton, M DelTatto, MS Dooner, MA Passero, PJ Quesenberry and JR Klinger. (2009). Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension. Stem Cells Dev 5:773-782.
47. Aliotta JM, M Pereira, A Amaral, A Sorokina, Z Igbinoba, A Hasslinger, R El-Bizri, SI Rounds, PJ Quesenberry and JR Klinger. (2013). Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotalinetreated mice. Cardiovasc Res 3:354-362.
48. Wen S. (2013). Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage. Abstract accepted to ASH Annual Meeting, New Orleans, LA
49. Renzulli JF 2nd, M Del Tatto, G Dooner, J Aliotta, L Goldstein, M Dooner, G Colvin, D Chatterjee and P Quesenberry. (2010). Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J Urol 5:2165-2171.
50. Del Tatto M, T Ng, JM Aliotta, GA Colvin, MS Dooner, D Berz, GJ Dooner, EF Papa, DC Hixson, et al. (2011). Marrow cell genetic phenotype change induced by human lung cancer cells. Exp Hematol 11:1072-1080.
51. Panagopoulos K, S Cross-Knorr, C Dillard, D Pantazatos, M Del Tatto, D Mills, L Goldstein, J Renzulli, P Quesenberry and D Chatterjee. (2013). Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure. Mol Cancer 1:118.
52. Bruno S, F Collino, MC Deregibus, C Grange, C Tetta and G Camussi. (2013). Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev 5:758-771.
53. Fonsato V, F Collino, MB Herrera, C Cavallari, MC Deregibus, B Cisterna, S Bruno, R Romagnoli, M Salizzoni, C Tetta and G Camussi. (2012). Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30:1985-1998.